PATENT CLAIM ANALYSIS

Application Number: 15910857
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["435", "006100"]

Abstract:
Disclosed herein, in certain embodiments, are methods and kits for diagnosing a subject as having hepatocellular carcinoma (HCC) or lung cancer. In some instances, also described herein are methods of determining the prognosis of the subject having HCC or lung cancer. In additional instances, described herein are methods of determining the specific staging of HCC or lung cancer in a subject.

Claim (Index 4):
The method of  claim 1 , wherein the gene is selected from BMPR1A, PSD, ARHGAP25, KLF3, PLAC8, ATXN1, Chromosome 6:170, Chromosome 6:3, ATAD2, and Chromosome 8:20.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 90.0
- Lexical Diversity: 1.89189
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15435174', '14986520', '14079649', '13408338', '15839318']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6586011457534271
- 35 USC 102 Novelty (BERT): 0.5244092761615247
- Combined Prediction Score: 0.6451819587942369
- Mean Citation Score: 306.334042
- Max Citation Score: 339.3372
- Similarity Product: 235.3995356097221

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test